|
|
NAVB Oldtimers Lounge
|
|
||
Dr Grinspoon 2016 Laureate (Responsible Party NAVB Tilmanocept Imaging Arterial Inflammation Study-study slide):LT Complications of HIV and Cardiovascular Disease--inflammation driven-current risk ID does not work-need new tests and treatments May 2017(note: TIL study results slide was included in training presentation. Training presentation focus on inflammation driven and current risk identification does not work and need to study new treatments) Clinical Trial: 99mTc Tilmanocept for Imaging Arterial Inflammation Identifier:
NCT02542371 Information provided by (Responsible Party):
Steven K. Grinspoon, MD, Massachusetts General Hospital |
return to message board, top of board |